SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) October 4, 2004
VARIAN MEDICAL SYSTEMS, INC.
--------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Delaware 1-7598 94-2359345
--------------------------------------------------------------------------------
(State or Other Jurisdiction (Commission File (IRS Employer
of Incorporation) Number) Identification No.)
3100 Hansen Way, Palo Alto, CA 94304-1030
--------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (650) 493-4000
Not Applicable
--------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
|_| Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
================================================================================
Item 2.02. Results of Operations and Financial Condition.
On October 4, 2004, Varian Medical Systems, Inc. issued a press release
regarding Demand for New IGRT-Enabled Products Helps to Drive Strong Order
Growth for Varian Medical Systems During Fourth Quarter of Fiscal 2004. A copy
of the press release is attached as Exhibit 99.1 and incorporated herein by
reference.
Item 7.01. Regulation FD Disclosure.
On October 4, 2004, Varian Medical Systems, Inc. issued a press release
regarding Demand for New IGRT-Enabled Products Helps to Drive Strong Order
Growth for Varian Medical Systems During Fourth Quarter of Fiscal 2004. A copy
of the press release is attached as Exhibit 99.1 and incorporated herein by
reference.
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits.
99.1 Press Release dated October 4, 2004 regarding Demand for New
IGRT-Enabled Products Helps to Drive Strong Order Growth for Varian Medical
Systems During Fourth Quarter of Fiscal 2004.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Varian Medical Systems, Inc.
By: /s/ JOSEPH B. PHAIR
-------------------------------
Name: Joseph B. Phair
Title: Vice President, Administration,
General Counsel and Secretary
Dated: October 4, 2004
3
EXHIBIT INDEX
Number Exhibit
------ -------
99.1 Press Release dated October 4, 2004 regarding Demand for New
IGRT-Enabled Products Helps to Drive Strong Order Growth for
Varian Medical Systems During Fourth Quarter of Fiscal 2004.